Position Paper on Promotion of Therapeutic GoodsThe relationship between health care professionals and therapeutic goods companies is governed by industry and professional codes of conduct or practice rather than by government regulation. Current codes vary in their definitions, member obligations, scope of application, enforcement and penalties. There is a broad acceptance by industry of the need to reform the existing self-regulatory arrangements.
The Position Paper on the Promotion of Therapeutic Goods, released on 30 June 2010 by the then Parliamentary Secretary, the Hon Mark Butler MP, called on industry to strengthen and standardise self-regulation through the use of codes based on consistent industry-wide high level principles.
Position Paper on the Promotion of Therapeutic Goods (Word 16 KB)
Position Paper on the Promotion of Therapeutic Goods printable version (PDF 24 KB)
Stakeholder submissions to the Position PaperThe Government received 39 submissions in response to the Position Paper. Note: submissions made by private individuals have had their personal contact details removed.
The Working Group on Promotion of Therapeutic ProductsA Working Group comprising industry stakeholders, health professional organisations and consumers was established to consider submissions to the Position Paper and develop a set of high level principles. Members of the Working Group are listed here.
|Anne Trimmer||Medical Technology Association of Australia (Chair)|
|Troy Williams||Australian Dental Industry Association|
|Dr Roderick McRae||Australian Medical Association|
|Elizabeth Foley||Australian Nursing Federation|
|Dr Deon Schoombie||Australian Self Medication Industry|
|Dr Wendy Morrow||Complementary Healthcare Council of Australia|
|Carol Bennett||Consumers Health Forum of Australia Inc|
|Kate Lynch||Generic Medicines Industry Association|
|Dr Peter Harman||IVD Australia|
|Dr Brendan Shaw||Medicines Australia|
|Mark Feldschuh||Pharmaceutical Society of Australia|
|Anne Develin||Pharmacy Guild of Australia|
|Mary Osborn||Royal Australasian College of Physicians|
|Dr Ken Harvey||School of Public Health, Latrobe University|
Working Group Report - Promotion of Therapeutic ProductsThe then Parliamentary Secretary for Health and Ageing, the Hon Catherine King MP, welcomed the report of the Working Group on Promotion of Therapeutic Products. The Working Group made a number of recommendations for industry, government and healthcare professionals and the report includes a set of high level principles as the basis for strengthening and aligning industry codes of conduct.
Working Group on Promotion of Therapeutic Products report (Word 624 KB)
Working Group on Promotion of Therapeutic Products report Printable Version (PDF 161 KB)
The Australian Government’s preference is to maintain an emphasis on self-regulation and it strongly supports industry’s initiative to harmonise their codes of conduct to incorporate the Working Group’s high level principles. The Government has carefully considered the Working Group’s report and responded in its overall response to reform of the therapeutic goods regulatory framework TGA Reforms: A blueprint for TGA's future.
In July 2012, a detailed implementation plan, Delivering reforms - Implementation plan for TGA Reforms: A blueprint for TGA's future, was released for the reforms outlined in the Blueprint, including recommendations of the Working Group.
Strengthening Codes of Conduct and Transparency in Industry Promotion of Therapeutic GoodsIn the 2012-13 Budget, the Australian Government provided $1.4 million over four years to assist industry to implement the recommendations of the Working Group on Promotion of Therapeutic Goods.
The measure provided funding to support an implementation advisory group to guide and oversee the review and alignment of industry associations' codes of conduct with the Working Group's framework of high-level principles, design and development of a shared information system and common complaints portal, and an independent evaluation of the effectiveness of the self-regulatory framework.
Codes of Conduct Advisory GroupThe Codes of Conduct Advisory Group (the Advisory Group) was established in January-February 2013. The membership of the Advisory Group includes representatives from industry associations, and healthcare professional and consumer stakeholders. The members of the Advisory Group are listed below:
|Professor Lloyd Sansom||University of South Australia (Chair)|
|Dr Angela Pierce||Australian Dental Association|
|Mr Troy Williams||Australian Dental Industry Association|
|Dr Gino Pecoraro||Australian Medical Association|
|Ms Elizabeth Foley||Australian Nursing Federation|
|Mr Steve Scarff||Australian Self Medication Industry|
|Ms Alina Tooley||AusBiotech|
|Mr Richard Henfrey||Complementary Healthcare Council of Australia|
|Ms Anne McKenzie||Consumers Health Forum of Australia Inc|
|Ms Kate Lynch||Generic Medicines Industry Association|
|Mr Graeme Bulman||IVD Australia|
|Dr Brendan Shaw||Medicines Australia|
|Ms Anne Trimmer||Medical Technology Association of Australia|
|Mr Grant Kardachi||Pharmaceutical Society of Australia|
|Ms Anne Develin||Pharmacy Guild of Australia|
|Dr Catherine Streeton||Royal Australasian College of Physicians|
|Professor Alan Bensoussan||Centre for Complementary Medicine Research|
The Terms of Reference for the Advisory Group can be found at: Terms of Reference.
The Advisory Group held its first meeting on 5 March 2013. A report of the Advisory Group's first meeting can be found at: First Meeting
Please note this page is an updated version. Please find previous version of Promotion of Therapeutic Goods.